-
Je něco špatně v tomto záznamu ?
Attenuated neutralization, maintained specificity: Humoral response to SARS-CoV-2 booster in kidney allograft recipients
M. Fialova, E. Cecrdlova, I. Zahradka, V. Petr, F. Hruby, I. Modos, O. Viklicky, I. Striz
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- COVID-19 * imunologie prevence a kontrola MeSH
- dospělí MeSH
- glykoprotein S, koronavirus imunologie MeSH
- humorální imunita MeSH
- lidé středního věku MeSH
- lidé MeSH
- neutralizující protilátky * krev imunologie MeSH
- příjemce transplantátu * MeSH
- protilátky virové * krev imunologie MeSH
- SARS-CoV-2 * imunologie MeSH
- sekundární imunizace MeSH
- senioři MeSH
- transplantace ledvin * škodlivé účinky MeSH
- vakcína BNT162 imunologie aplikace a dávkování MeSH
- vakcíny proti COVID-19 imunologie aplikace a dávkování MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Despite the lower virulence of current SARS-CoV-2 variants and high rates of vaccinated and previously infected subjects, COVID-19 remains a persistent threat in kidney transplant recipients (KTRs). This study evaluated the parameters of anti-SARS-CoV-2 antibody production in 120 KTRs. The production of neutralizing antibodies in KTRs, following booster vaccination with the mRNA vaccine BNT162b2, was significantly decreased and their decline was faster than in healthy subjects. Factors predisposing to the downregulation of anti-SARS-CoV-2 neutralizing antibodies included age, lower estimated glomerular filtration rate, and a full dose of mycophenolate mofetil. Neutralizing antibodies correlated with those targeting the SARS-CoV-2 receptor binding domain (RBD), SARS-CoV-2 Spike trimmer, total SARS-CoV-2 S1 protein, as well as with antibodies to the deadly SARS-CoV-1 virus. No cross-reactivity was found with antibodies against seasonal coronaviruses. KTRs exhibited lower postvaccination production of neutralizing antibodies against SARS-CoV-2; however, the specificity of their humoral response did not differ compared to healthy subjects.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25002899
- 003
- CZ-PrNML
- 005
- 20250206103932.0
- 007
- ta
- 008
- 250121s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.diagmicrobio.2024.116550 $2 doi
- 035 __
- $a (PubMed)39437653
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Fialova, Martina $u Department of Clinical and Transplant Immunology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 245 10
- $a Attenuated neutralization, maintained specificity: Humoral response to SARS-CoV-2 booster in kidney allograft recipients / $c M. Fialova, E. Cecrdlova, I. Zahradka, V. Petr, F. Hruby, I. Modos, O. Viklicky, I. Striz
- 520 9_
- $a Despite the lower virulence of current SARS-CoV-2 variants and high rates of vaccinated and previously infected subjects, COVID-19 remains a persistent threat in kidney transplant recipients (KTRs). This study evaluated the parameters of anti-SARS-CoV-2 antibody production in 120 KTRs. The production of neutralizing antibodies in KTRs, following booster vaccination with the mRNA vaccine BNT162b2, was significantly decreased and their decline was faster than in healthy subjects. Factors predisposing to the downregulation of anti-SARS-CoV-2 neutralizing antibodies included age, lower estimated glomerular filtration rate, and a full dose of mycophenolate mofetil. Neutralizing antibodies correlated with those targeting the SARS-CoV-2 receptor binding domain (RBD), SARS-CoV-2 Spike trimmer, total SARS-CoV-2 S1 protein, as well as with antibodies to the deadly SARS-CoV-1 virus. No cross-reactivity was found with antibodies against seasonal coronaviruses. KTRs exhibited lower postvaccination production of neutralizing antibodies against SARS-CoV-2; however, the specificity of their humoral response did not differ compared to healthy subjects.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a neutralizující protilátky $x krev $x imunologie $7 D057134
- 650 12
- $a transplantace ledvin $x škodlivé účinky $7 D016030
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a protilátky virové $x krev $x imunologie $7 D000914
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a COVID-19 $x imunologie $x prevence a kontrola $7 D000086382
- 650 12
- $a SARS-CoV-2 $x imunologie $7 D000086402
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 12
- $a příjemce transplantátu $7 D066027
- 650 _2
- $a humorální imunita $7 D056724
- 650 _2
- $a sekundární imunizace $7 D007117
- 650 _2
- $a vakcína BNT162 $x imunologie $x aplikace a dávkování $7 D000090982
- 650 _2
- $a glykoprotein S, koronavirus $x imunologie $7 D064370
- 650 _2
- $a vakcíny proti COVID-19 $x imunologie $x aplikace a dávkování $7 D000086663
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Cecrdlova, Eva $u Department of Clinical and Transplant Immunology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Zahradka, Ivan $u Department of Nephrology, Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Petr, Vojtech $u Department of Nephrology, Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Hruby, Filip $u Information Technology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Modos, Istvan $u Information Technology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Viklicky, Ondrej $u Department of Nephrology, Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Striz, Ilja $u Department of Clinical and Transplant Immunology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Electronic address: ilja.striz@ikem.cz
- 773 0_
- $w MED00001396 $t Diagnostic microbiology and infectious disease $x 1879-0070 $g Roč. 111, č. 1 (2025), s. 116550
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39437653 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206103927 $b ABA008
- 999 __
- $a ok $b bmc $g 2262974 $s 1238906
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 111 $c 1 $d 116550 $e 20241016 $i 1879-0070 $m Diagnostic microbiology and infectious disease $n Diagn Microbiol Infect Dis $x MED00001396
- LZP __
- $a Pubmed-20250121